172@29@16@22!~!172@29@0@53!~!|stocks|stock_market|corp_notices.php?autono=22224881!~!www|moneycontrol|com!~!|stocks|stock_market|corp_notices.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

22nd-Sep-2020 11:24Source: BSE

Cadila Healthcare - Announcement under Regulation 30 (LODR)-Credit Rating

We would like to inform that CRISIL has, after due deliberations, reaffirmed its ''CRISIL A1+'' (pronounced as CRISIL A one plus rating) on the Rs. 1,300 crore Commercial Paper (enhanced from Rs. 250 crore) of the Company.

The credit rating letter dated September 21, 2020 received from CRISIL is enclosed.

Board Meeting (Cadila Health)

Meeting Date

Remark

2020-11-02

Quarterly Results

Sections